Development of a beta cell-specific expression control element for rAAV.

Diabetes mellitus, caused by loss or dysfunction of the insulin producing beta cells of the pancreas, is a promising target for rAAV-mediated gene therapy. To target potential therapeutic payloads specifically to beta cells, a cell-type specific expression control element is needed. Here, we tested a series of rAAV vectors designed to express transgenes specifically in human beta cells using the islet-tropic rAAV-KP1 capsid. A small promoter, consisting of only 84 bp of the insulin core promoter was not beta cell-specific in AAV, but highly active in multiple cell types, including tissues outside the pancreas. A larger 363 bp fragment of the insulin promoter (INS) also lacked beta cell specificity. However, beta cell-specific expression was achieved by combining two regulatory elements, a promoter consisting of two copies of INS (INSx2) and microRNA (miRNA) regulatory elements (MREs). The INSx2 promoter alone showed some beta cell preference, but not tight specificity. To reduce unspecific transgene expression in alpha cells, negative regulation by miRNAs was applied. MREs that are recognized by miRNAs abundant in alpha cells effectively downregulated the transgene expression in these cells. The INS2x-MRE expression vector was highly specific to human beta cells and stem cell derived beta cells.

[1]  R. Stein,et al.  Loss of the transcription factor MAFB limits β-cell derivation from human PSCs , 2020, Nature Communications.

[2]  M. Kay,et al.  Using a barcoded AAV capsid library to select for novel clinically relevant gene therapy vectors , 2019, bioRxiv.

[3]  S. Mundlos,et al.  Regulatory Landscaping: How Enhancer-Promoter Communication Is Sculpted in 3D. , 2019, Molecular cell.

[4]  Gopika G. Nair,et al.  Recapitulating endocrine cell clustering in culture promotes maturation of human stem-cell-derived β cells , 2019, Nature Cell Biology.

[5]  A. Novials,et al.  Stress-Induced MicroRNA-708 Impairs β-Cell Function and Growth , 2017, Diabetes.

[6]  H. Thomas,et al.  Transplantation sites for human and murine islets , 2017, Diabetologia.

[7]  A. Shalev,et al.  β-Cell MicroRNAs: Small but Powerful , 2015, Diabetes.

[8]  Jonathan Schug,et al.  Epigenetic regulation of the DLK1-MEG3 microRNA cluster in human type 2 diabetic islets. , 2014, Cell metabolism.

[9]  Nicholas T. Ingolia,et al.  Mammalian microRNAs predominantly act to decrease target mRNA levels , 2010, Nature.

[10]  M. Grompe,et al.  Isolation of major pancreatic cell types and long-term culture-initiating cells using novel human surface markers. , 2008, Stem cell research.

[11]  N. Tanaka,et al.  Development of a novel beta-cell specific promoter system for the identification of insulin-producing cells in in vitro cell cultures. , 2006, Experimental cell research.

[12]  N. Welsh,et al.  A perfusion protocol for highly efficient transduction of intact pancreatic islets of Langerhans , 2006, Diabetologia.

[13]  Y. Ben-Neriah,et al.  Glucose modulates the binding of an islet-specific factor to a conserved sequence within the rat I and the human insulin promoters. , 1993, Proceedings of the National Academy of Sciences of the United States of America.